Results 71 to 80 of about 9,108 (207)

The anti-tumor efficacy of nanoparticulate form of ICD-85 versus free form

open access: yesArchives of Razi Institute, 2015
Biodegradable polymeric nanoparticles (NPs) have been intensively studied as a possible way to enhance anti-tumor efficacy while reducing side effects. ICD-85, derived from the venom of two separate species of venomous animals, has been shown to exhibit ...
Zare Mirakabadi, A.   +4 more
doaj  

Spatial Accessibility Analysis of Snake Antivenom

open access: yesInternational Journal of Public Health
ObjectivesTo analyze the spatial accessibility of antivenom immunizing agents equipped hospitals in Hainan Province.MethodsThis paper analyzes the spatial accessibility of medical institutions equipped with different types of snake antivenom using ...
Wenjie Hao   +7 more
doaj   +1 more source

The Clinical Usefulness of Taiwan Bivalent Freeze-Dried Hemorrhagic Antivenom in Protobothrops mucrosquamatus- and Viridovipera stejnegeri-Envenomed Patients

open access: yesToxins, 2022
Snakebites from Protobothrops mucrosquamatus (Taiwan habus) and Viridovipera stejnegeri (green bamboo vipers) account for the most venomous snakebites in Taiwan.
Chih-Chuan Lin   +6 more
doaj   +1 more source

A Century of Antivenom

open access: yesCollegium antropologicum, 2011
Because it primarily affects the poor in undeveloped parts of the world where medical care is often inadequate and insufficient, envenomation is considered a neglected public health issue, despite the existence of antivenom therapy for more than a century. This article provides an overview of the epidemiological situation for important venomous animals,
Lovreček, Dijana, Tomić, Siniša
openaire   +3 more sources

Cross-neutralisation of Australian brown and tiger snake venoms with commercial antivenoms: Cross-reactivity or antivenom mixtures?

open access: yes, 2007
Recently it has been suggested that the Australian snake antivenoms made by CSL Ltd. are in fact not truly monovalent and may contain antibodies to other snake venoms because the horses are injected with multiple snake venoms.
Ong, Lin Kooi   +6 more
core   +1 more source

Allergic reactions to antivenom in a patient bitten twice by the same snake within a month: A rare case report and literature review

open access: yesChinese Journal of Traumatology, 2017
Antivenom is the most effective method currently available for the treatment of poisonous snake bite. Allergic reactions to antivenom have been reported in the past.
Fan-Jie Zeng, Cong Chen, Ming-Hua Liu
doaj   +1 more source

Challenges in care of snake envenomation in rural Pakistan: a narrative review

open access: yesToxicology Communications, 2023
Snake envenomation remains a neglected tropical disease in Pakistan per the World Health Organization, with approximately 40,000 bites and 8,200 fatalities annually.
Rmaah Memon   +2 more
doaj   +1 more source

A Case of Naja atra Bite Complicated by Gas Gangrene Leading to Amputation: Pathogen and Management Lessons

open access: yesClinical Case Reports, Volume 14, Issue 7, July 2026.
Gas gangrene of the right upper limb following a Naja atra bite, with extensive skin necrosis and purulent discharge. ABSTRACT Gas gangrene after a Naja atra bite may be caused by Enterococcus faecalis from the snake's mouth, which is resistant to ceftriaxone.
Xuan Ci   +5 more
wiley   +1 more source

Plots of the observed antivenom concentration (μg/ml) versus time for patients given a single dose of antivenom (A), and for patients given multiple antivenom doses (B).

open access: yes, 2015
Plots of the observed antivenom concentration (μg/ml) versus time for patients given a single dose of antivenom (A), and for patients given multiple antivenom doses (B).
Geoffrey K. Isbister (131304)   +13 more
core   +1 more source

Enhancing the Bothropic Antivenom through a Reverse Antivenomics Approach

open access: yesJournal of Proteome Research
Antivenoms are the only effective treatment for snakebite envenomation and have saved countless lives over more than a century. Despite their value, antivenoms present risks of adverse reactions. Current formulations contain a fraction of nonspecific antibodies and serum proteins.
Tassia Chiarelli   +8 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy